Tenzing Acquisition Corp. (TZAC) to Combine with Reviva Pharmaceuticals

Reviva-Pharmaceuticals

Tenzing Acquisition Corp. (TZAC) to Combine with Reviva Pharmaceuticals

Jul 21, 2020 INTEL by Kristi Marvin
Tenzing Acquisition Corp. (TZAC), announced this morning that they have signed a definitive agreement and plan of merger (the “Merger Agreement”) for a business combination with Reviva Pharmaceuticals, Inc. (“Reviva”), a California-based clinical stage pharmaceutical company developing therapies that address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

Leave a Reply